In previous studies, urinary EGF, a novel biomarker of renal fibrosis, was identified as an independent predictor of CKD progression, and the addition of urinary EGF to standard parameters could improve the prediction of disease events in diverse CKD populations [28]. The gene discussed is EGF; the disease is renal fibrosis.